Geographic Optimization of Liver Allocation in Transplantation

Size: px
Start display at page:

Download "Geographic Optimization of Liver Allocation in Transplantation"

Transcription

1 1 1 Geographic Optimization of Liver Allocation in Transplantation Esri Health GIS Conference Florian Bayer, Dr. Christian Jacquelinet, Benoit Audry, Dr. Corinne Antoine

2 2 2 a - Introduction Study Objectives Overall context : How can spatial analysis and geography improve organ allocation? How can liver allocation processes be improved? What compromise between the recipient s condition and organ transport requirements

3 3 3 a - Introduction Contents 1. Context: French liver transplant organ allocation rules 2. Methodology 3. Results 4. Conclusion and future work

4 Context

5 Context L Agence de la biomédecine Created by the bioethics law of August 6, 2004 from the Etablissement Français des Greffes created in 1994 French public body Responsible for: - Operational coordination and administration of organ transplantation and tissue harvesting - Coordination and administration of hematopoietic stem cell grafting - Administration of assisted reproductive technology, human embryology and human genetics

6 1 - Context L Agence de la biomédecine It is responsible for Organ allocation rules and the national waiting list To ensure the impartial distribution of organs to the most appropriate recipient To make an optimal compromise between efficacy, equity and feasibility In liver transplant, this compromise must take into account : Specific recipient condition (i.e. emergency life threatening conditions) The quality/safety of the transplant and organ The distance between donor and transplant centres (cold ischemia time, transplantation team s security ) 6 6

7 Context Liver Score The Liver Score was introduced in March 2007 Ł To attribute livers to the best recipient, by "just-in-time" optimisation Ł Without excluding potential recipients

8 Context Liver Score Set of functions based on : 1. The recipient s health using the MELD (Model for End-Stage Liver Disease) for cirrhosis, and waiting time for hepatocellular carcinoma. estimating the risk of death on the waiting list. 2. The distance between donor and transplant centres To reduce team s travel To reduce cold ischemia To take into account the team s location whilst removing the frontier effect 3. Time spent on the waiting list Accelerate access to transplantation while patients are still in the optimal period 4. Documented recourse to Experts to deal with exceptional circumstances

9 1 - Context Liver Score V1,V2,V3 V4 Disparity of local networks in hepatic transplantation in 2010 Urgency Urgency Local Liver Score Liver Score Exceptional Allocation Exceptional Allocation 9 9

10 Context Percentage of local network transplants by team

11 Context The distance in the Liver Score Double geographic model : Local : the distance doesn t matter National : the distance matters Sicker patients further from the organ or outside the network could benefit from the local organ, but don t. The coverage of just-in-time principle of the Liver Score was only partial Problem of Efficacy and equity

12 Context Objectives 1. Optimising the distance function in the current Liver Score by linking the key decision factors of liver transplant : The distance between donor and transplant team The recipient s health (The organ quality) 2. To show that an alternative to a local network is conceivable Without reducing organ procurement and transplant activity Making a compromise between seriousness of the condition and distance

13 Methodology

14 Methodology Methodology 1/ Review of existing studies u essentially about finding the best static area for transplantation 2/ Finding the best geographical theory and tools for this study u The principles of spatial interaction 3/ Integration of these principles in the Liver Score a. Optimization of the new model with Arcgis b. Tests and simulations with Arcgis (day to day) and with our simulation platform (years)

15 Methodology The principles of spatial interaction 1 st : size effect At equal distance, the importance of relations between two places is equal to their ability to transmit and receive 2 nd : distance effect At equal weight, the importance of relations between two places is inversely proportional to their distance 3 rd : frontier effect Size (population) High Low Attractivity Source : Claude Grasland

16 Methodology Some principles of spatial interaction u Strong analogy with the Newton's law of universal gravitation. u Application to geography (Pareto / Stewart / Reilly s law) : «The force of attraction exerted by a place j on place i is proportional to its size and inversely proportional to the square of the distance from i to j» Aij = Mj X Mi / Dij 2 Aij attractivity of j on i i the location of the transplant team j the localisation of the patient on the waiting list Mj the j mass Mi the i mass Dij the distance between i and j

17 Methodology Some principles of spatial interaction High Liver Score without distance Low Liver Score without distance Graft Attraction Assess this attraction with the liver score without distance and the distance to the organ. This compromise depends on the distance decay (entropy principle).

18 Methodology The «basic» model Aij = Mj X Mi / Dij α Mj the mass of the patient on the waiting list Liver Score without distance component Mi the mass of the graft status At this time, no consensus for its evaluation. Mi = 1 Distant Dij between i et j Travel time by road The last parameter is α, the distance decay (entropy). It was calibrated with a linear regression based on real teams flow. A VBA Arcgis tool has been developped for adjustements

19 Methodology Methodology Data : liver transplant ( ) Geocoding Arcmap linear regression Sas VBA Arcgis Geographic data Day to day simulation Setting parameters Annual simulation Arcmap Arcmap Simulation platform

20 Methodology Expectations Better compromise between distance and recipient s health Potentially an organ can now be distributed : 1. All over the territory for the sickest patients : gravity > distance 2. Near the liver procurement team for the less urgent : distance > gravity This reducing teams transport (time, costs and risks) February 2011 : implementation of the gravity model Score = Score HD / exp [ 0,4 x [ (DLPG) / (seuil)] 0,15 ]

21 Results

22 3 - Results Results : day to day Fictive patients waiting list for a liver transplantation Patient Rank (score without distance) Liver score without distance Score V3 Score 1 (900) Bordeaux Bordeaux Bordeaux V4 2 (870) Paris 1 Paris 1 Paris 1 3 (845) Paris 2 Paris 2 Paris 2 4 (610) Marseille Rennes Rennes 5 (610) Grenoble Caen Marseille 6 (588) Lyon Lille Grenoble 7 (573) Toulouse Besançon Caen 8 (553) Besançon Marseille Lyon 9 (540) Rennes Toulouse Toulouse 10 (529) Caen Strasbourg Besançon 11 (520) Lille Lyon Lille 12 (493) Strasbourg Grenoble Strasbourg Donor liver 13 (478) Montpellier Montpellier Montpellier 14 (470) Nice Nice Nice 22

23 Results Area of certitude to be the first on the waiting list, for each patient according to their severity score and the model used (same list as before) Liver Score V3 Liver Score V4 more local competition p2 p10 p3 p2 p11 p6 p9 p5 p1 p1 p4 Patient area of certitude to get the graft (2 areas) Patient area of certitude to get the graft (14 areas) Source : Agence de la biomédecine 2009

24 Results Area of certitude to be the first on the waiting list, for each patient according to their severity score and the model used (same list as before) Liver Score V4 Day 1 Liver Score V4 Day 2 (Paris Lyon Score 720 Bordeaux 500 ) Patient area of certitude to get the graft (14 areas) Patient area of certitude to get the graft (14 areas)

25 Results V1/V2 V3 V4

26 Results Cumulative incidence rate Score V3 : death and delisting (aggravated condition) stratified by inscription MELD (cirrhosis) Score V4 : death and delisting (aggravated condition) stratified by inscription MELD (cirrhosis) Cumulative incidence rate Months Benefice for every MELD class, except [26-29] High competition with hepatocellular carcinoma Months

27 Results Meld class distribution by km from 02/22/2010 to 02/21/2011 for Cirrhosis (without HCC) local and national score V3 (n=335) 70 De 0 à 150 km (n=169) De 150 à 300 km (n=41) Plus de 300 km (n=125) [06-10] (n=8) [11-14] (n=21) [15-19] (n=36) [20-25] (n=77) [26-29] (n=54) [30-34] (n=50) [35-40] (n=89)

28 Results Meld class distribution by km from 02/22/2011 to 02/21/2012 for Cirrhosis (without HCC) local and national score V4 (n=329) 70 De 0 à 150 km (n=175) De 150 à 300 km (n=48) plus de 300 km (n=106) [06-10] (n=0) [11-14] (n=2) [15-19] (n=30) [20-25] (n=90) [26-29] (n=47) [30-34] (n=65) [35-40] (n=95)

29 Results Montpellier team s travel for liver score transplantation between february 2010 and february 2011 Montpellier team s travel for liver score transplantation between february 2011 and february km less for all transplantation teams between V3 and V4, with the same activity

30 Results Deciles distribution of cold ischemia time Global reduction of cold ischemia time : 491 (v3) to 470 (v4) minutes on average

31 Conclusion

32 Conclusion Limits The main inconvenience of such an approach is the understandability of the model for clinicians, patients and citizens. Advantages Applying the gravity model allows slightly improving access to transplantation for the most urgent patients Team transport and cold ischemia time decrease Better compromise between distance and urgency Significant decrease in death and delisting due to worsening health (-15%), together with a reduction of disparities according to MELD, indications and centers

33 Conclusion Futur works Taking into account health care professionals feedback for model adjustments Evaluation of post-transplant survival Professionals still working on a better recipient priority score for hepatocellular carcinoma Working on the same approach for the Kidney matching Score

34 34 Thank you for your attention Benoît Rajau pour l Agence de la biomédecine Contributeurs de OpenStreetMap. Tiles courtesy of Humanitarian OpenStreetMap Team

Florian Bayer Dr. Christian Jacquelinet Benoit Audry

Florian Bayer Dr. Christian Jacquelinet Benoit Audry 1 Using a gravity model for allocation o of livers to transplant Florian Bayer Dr. Christian Jacquelinet Benoit Audry 2 a -Introduction Study Objectives Global context : What can be the contribution of

More information

Disparities in Liver Transplant Allocation: An Update on MELD Allocation System

Disparities in Liver Transplant Allocation: An Update on MELD Allocation System Disparities in Liver Transplant Allocation: An Update on MELD Allocation System Naudia L. Jonassaint, MD MHS Assistant Professor of Medicine and Surgery University of Pittsburgh School of Medicine Historical

More information

Organ Allocation in Pennsylvania: Current concepts and future directions

Organ Allocation in Pennsylvania: Current concepts and future directions Organ Allocation in Pennsylvania: Current concepts and future directions David Goldberg, MD, MSCE Assistant Professor of Medicine and Epidemiology Medical Director of Living Donor Liver Transplantation

More information

Using GIS for Analyzing Optimal Organ Allocation for Liver Transplantation

Using GIS for Analyzing Optimal Organ Allocation for Liver Transplantation Using GIS for Analyzing Optimal Organ Allocation for Liver Transplantation September 7, 2011 1 Presenters: Naoru Koizumi 1, Amit Patel 1,Yang Xu 1, Nigel Waters 1, Monica Gentili 2, Ammar Malik 1, Dennis

More information

The transplant benefit score and the national liver offering scheme

The transplant benefit score and the national liver offering scheme The transplant benefit score and the national liver offering scheme New national offering scheme The development of a national set of rules to offer livers to named adult patients on the elective liver

More information

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health An Agency of the French Ministry of Health Transparency, Equity, Ethics: Improving access to care and patients quality of life AgenceBiomedecine_Plaquette_GB.indd 1 25/08/14 12:15 Contents P.1 Agence de

More information

Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score

Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score American Journal of Transplantation 2006; 6: 2470 2475 Blackwell Munksgaard C 2006 The Authors Journal compilation C 2006 The American Society of Transplantation and the American Society of Transplant

More information

Current strategies to kidney allocation

Current strategies to kidney allocation Current strategies to kidney allocation Dr Marie Alice Macher Dr Christian Jacquelinet Emilie Savoye Dr Corinne Antoine Direction Prélèvement Greffe organes - tissus From organ sharing to organ allocation

More information

Evaluation Process for Liver Transplant Candidates

Evaluation Process for Liver Transplant Candidates Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection

More information

EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study

EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study EVATEL Study Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study Philippe Mabo, Pascal Defaye, Nicolas Sadoul, Jean Marc Davy, Jean-Claude Deharo, Salem Kacet, Eric

More information

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures The new kidney allocation system (KAS) what has it done? Disclosures No financial disclosure Ryutaro Hirose, MD Professor in Clinical Surgery University of California San Francisco Objectives Describe

More information

Faiez Zannad, MD, PhD, Nancy

Faiez Zannad, MD, PhD, Nancy 1 Biotargets, drug discovery and therapeutic innovation. How French clinical networks can accelerate the discovery of new treatments in the field of cardiovascular and metabolic diseases? Faiez Zannad,

More information

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014 Renal Transplantation: Allocation challenges and changes Mark R. Wakefield, M.D., F.A.C.S. Associate Professor of Surgery/Urology Director Renal Transplantation Renal Transplantation Objectives: Understand

More information

Historical perspective (2)

Historical perspective (2) Experience from Public Health System : French CECOS experience Dominique ROYERE Médecine et Biologie de la Reproduction Cecos de Tours, France Historical perspective (2) To understand what was the context

More information

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME INTRODUCTION 1 Three working groups were established to consider whether changes were

More information

Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery. Would you accept this offer?

Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery. Would you accept this offer? Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery Question 1: A 19 y/o deceased donor kidney (O mismatch) from NYC is allocated to a 72 y/o highly sensitized caucasian

More information

National liver offering scheme

National liver offering scheme 1 National liver offering scheme Outline 1 Hub Specialist Nurse Organ Donation (SNOD) registers donor with Operations 2 matching Hub Operations initiates the run 3 Hub Matching run offering list printed

More information

Recent Developments in Cardiothoracic Transplantation

Recent Developments in Cardiothoracic Transplantation Recent Developments in Cardiothoracic Transplantation Sally Rushton Statistics and Clinical Studies NHS Blood and Transplant BTS March 2018 Content Heart and lung transplant activity over last decade Heart

More information

Evaluation Process for Liver Transplant Candidates

Evaluation Process for Liver Transplant Candidates Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection

More information

Optimal management of auto-immune

Optimal management of auto-immune collaborations des équipes impliquées dans l' explorati en charge des ef ets indésirables des immunothérapies INSCRIPTIONS BLIC : cialistes d organe, Chercheur s, ovigilants ns l es toxicités es anti-cancéreuses.

More information

1 -Context. The REIN registry

1 -Context. The REIN registry Operational maps for dialysis centers access time in France Florian Bayer Docteur Cécile Couchoud Docteur Christian Jacquelinet Docteur Jean-François Cabanne 1 1 -Context The REIN registry The French Renal

More information

Organ allocation for liver transplantation: Is MELD the answer? North American experience

Organ allocation for liver transplantation: Is MELD the answer? North American experience Organ allocation for liver transplantation: Is MELD the answer? North American experience Douglas M. Heuman, MD Virginia Commonwealth University Richmond, VA, USA March 1998: US Department of Health and

More information

Candidates about. Lung Allocation Policy. for Transplant. Questions & A n s we r s TA L K I N G A B O U T T R A N S P L A N TAT I O N

Candidates about. Lung Allocation Policy. for Transplant. Questions & A n s we r s TA L K I N G A B O U T T R A N S P L A N TAT I O N TA L K I N G A B O U T T R A N S P L A N TAT I O N Questions & A n s we r s for Transplant Candidates about Lung Allocation Policy U N I T E D N E T W O R K F O R O R G A N S H A R I N G What are the OPTN

More information

Development of the Allocation System for Deceased Donor Liver Transplantation

Development of the Allocation System for Deceased Donor Liver Transplantation Clinical Medicine & Research Volume 3, Number 2: 87-92 2005 Marshfield Clinic http://www.clinmedres.org Review Development of the Allocation System for Deceased Donor Liver Transplantation John M. Coombes,

More information

Administration of research

Administration of research Julian Tugaut Resume Experience 01/12/2015 Habilitation, Saint-Étienne. 2013 Associate Professor, Télécom - Institut Camille Jordan, Saint-Étienne (France). 2010 2013 Postdoc, Bielefeld (Germany). two

More information

Liver and intestine transplantation: summary analysis,

Liver and intestine transplantation: summary analysis, American Journal of Transplantation 25; 5 (Part 2): 916 933 Blackwell Munksgaard Blackwell Munksgaard 25 Liver and intestine transplantation: summary analysis, 1994 23 Douglas W. Hanto a,, Thomas M. Fishbein

More information

The French Organ Transplant Data System

The French Organ Transplant Data System 77 The French Organ Transplant Data System William Nigel Strang, Philippe Tuppin, Alain Atinault, Christian Jacquelinet Agence de la biomédecine 1 avenue Stade de France 93212 SAINT DENIS LA PLAINE CEDEX

More information

The Kidney Allocation System Changed in a Substantive Way on December 5, Your Patients Have Been, and Will Be, Affected by These Changes

The Kidney Allocation System Changed in a Substantive Way on December 5, Your Patients Have Been, and Will Be, Affected by These Changes The Kidney Allocation System Changed in a Substantive Way on December 5, 2014 Your Patients Have Been, and Will Be, Affected by These Changes 1 The New Kidney Allocation System Terms of Importance Pediatric

More information

Who are UNOS and the OPTN? What is the lung allocation system?

Who are UNOS and the OPTN? What is the lung allocation system? TA L K I N G A B O U T T R A N S P L A N TAT I O N Who are UNOS and the OPTN? United Network for Organ Sharing (UNOS) is a non-profit charitable organization that manages the nation s transplant system

More information

Consultation document on Organ Donation and Transplantation Response Form

Consultation document on Organ Donation and Transplantation Response Form Consultation document on Organ Donation and Transplantation Response Form Contact details of person and/or institution submitting comments Name of person Address e-mail address Knud Erben erben@ceapir.org

More information

Healthcare Disparities and Need for Transplant in our Multicultural Communities

Healthcare Disparities and Need for Transplant in our Multicultural Communities Healthcare Disparities and Need for Transplant in our Multicultural Communities AMAT 20 th Annual Meeting September 19, 2012 Anil S. Paramesh, MD, FACS Associate Professor of Surgery and Urology Tulane

More information

ORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1

ORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1 LIVER TRANSPLANTATION 18:914 929, 2012 ORIGINAL ARTICLE Recipient Survival and Graft Survival are Not Diminished by Simultaneous Liver-Kidney Transplantation: An Analysis of the United Network for Organ

More information

The pediatric end-stage liver disease (PELD) score

The pediatric end-stage liver disease (PELD) score Selection of Pediatric Candidates Under the PELD System Sue V. McDiarmid, 1 Robert M. Merion, 2 Dawn M. Dykstra, 2 and Ann M. Harper 3 Key Points 1. The PELD score accurately predicts the 3 month probability

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL193/6 Copy Number Effective 13/05/16 Summary of Significant Changes Para 1.3.1.6 - Amendment to donor and recipient age match points to reflect the fact that paediatric recipients

More information

The future of liver transplantation for viral hepatitis

The future of liver transplantation for viral hepatitis The future of liver transplantation for viral hepatitis François Durand Hepatology & Liver Intensive Care Hospital Beaujon, Clichy University Paris Diderot France Liver transplantation in France 2013:

More information

Information for patients (and their families) waiting for liver transplantation

Information for patients (and their families) waiting for liver transplantation Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation

More information

Organ Donation and Transplantation

Organ Donation and Transplantation Organ Donation and Transplantation Q: What is organ donation and transplantation? A: Organ transplantation is the surgical removal of an organ or tissues from one person (the donor) and placing it in another

More information

Molecular portraits/landscape of lung cancer in France

Molecular portraits/landscape of lung cancer in France Molecular portraits/landscape of lung cancer in France Jean-Charles SORIA Frédérique NOWAK Fabien CALVO U981 2 Disclosure Slide Member of the SAB of the french NCI (INCA). Appointed by the Ministry of

More information

Kidney vs. Liver: Where are We Really with Allocation in Kidney Transplantation?

Kidney vs. Liver: Where are We Really with Allocation in Kidney Transplantation? Kidney vs. Liver: Where are We Really with Allocation in Kidney Transplantation? Mark D. Stegall,, MD Chair, UNOS/OPTN Kidney Allocation Review Subcommittee Different Allocation Factors Liver Wait list

More information

CURRENT ALLOCATION POLICIES AND DISPARITIES WITHIN LIVER AND KIDNEY TRANSPLANTATION. Minja Gosto. BS, Allegheny College, 2010

CURRENT ALLOCATION POLICIES AND DISPARITIES WITHIN LIVER AND KIDNEY TRANSPLANTATION. Minja Gosto. BS, Allegheny College, 2010 CURRENT ALLOCATION POLICIES AND DISPARITIES WITHIN LIVER AND KIDNEY TRANSPLANTATION by Minja Gosto BS, Allegheny College, 2010 Submitted to the Graduate Faculty of Department of Epidemiology Graduate School

More information

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat

More information

Hépatite auto-immune. aigue sévère

Hépatite auto-immune. aigue sévère 9 eme journée des Centres de Reference et de Compétence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immune (MIVB-H) llaborat ions des équipes impliquées dans l' ex plora char

More information

Crime Research in Geography

Crime Research in Geography Crime Research in Geography Resource allocation: we helped design the police Basic Command Unit families for the national resource allocation formula in the 1990s. More recently been advising West Yorkshire

More information

The epidemiology of hepatitis C infection in Ontario, 2004

The epidemiology of hepatitis C infection in Ontario, 2004 The epidemiology of hepatitis C infection in Ontario, 2004 Robert S. Remis MD, MPH, FRCPC Department of Public Health Sciences University of Toronto Ontario Ontrario Harm Reduction Distribution Program

More information

OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation

OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation What problems is the proposal attempting to solve? Each zone = 500 mile radius Heart and Lung Allocation

More information

*APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor

*APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor APPENDIX 1 LIST OF COINVESTIGATORS *APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor M Vidaud; Hôpital Cochin-Necker: Professor S Pol, Professor Ph Sogni, Professor

More information

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION Adopted by the 63rd WMA General Assembly, Bangkok, Thailand, October 2012 PREAMBLE Advances in medical sciences, especially

More information

Trial and Cost Effectiveness Evaluation of Intra arterial Thrombectomy in Acute Ischemic Stroke

Trial and Cost Effectiveness Evaluation of Intra arterial Thrombectomy in Acute Ischemic Stroke Trial and Cost Effectiveness Evaluation of Intra arterial Thrombectomy in Acute Ischemic Stroke S. Bracard, F. Guillemin, X. Ducrocq for the THRACE investigators Disclosure Personal: No disclosure Study

More information

Death in patients waiting for liver transplantation. Liver Transplant Recipient Selection: MELD vs. Clinical Judgment

Death in patients waiting for liver transplantation. Liver Transplant Recipient Selection: MELD vs. Clinical Judgment ORIGINAL ARTICLES Liver Transplant Recipient Selection: MELD vs. Clinical Judgment Michael A. Fink, 1,2 Peter W. Angus, 1 Paul J. Gow, 1 S. Roger Berry, 1,2 Bao-Zhong Wang, 1,2 Vijayaragavan Muralidharan,

More information

Disparities in Transplantation Caution: Life is not fair.

Disparities in Transplantation Caution: Life is not fair. Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences

More information

Survival Benefit-Based Deceased-Donor Liver Allocation

Survival Benefit-Based Deceased-Donor Liver Allocation American Journal of Transplantation 2009; 9 (Part 2): 970 981 Wiley Periodicals Inc. No claim to original US government works Journal compilation C 2009 The American Society of Transplantation and the

More information

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017 Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen

More information

How to improve long term outcome after liver transplantation?

How to improve long term outcome after liver transplantation? How to improve long term outcome after liver transplantation? François Durand Hepatology & Liver Intensive Care University Paris Diderot INSERM U1149 Hôpital Beaujon, Clichy PHC 2018 www.aphc.info Long

More information

Hepatitis C: Difficult-to-treat Patients 11th Paris Hepatology Conference 16th January 2018 Stefan Zeuzem, MD University Hospital, Frankfurt, Germany

Hepatitis C: Difficult-to-treat Patients 11th Paris Hepatology Conference 16th January 2018 Stefan Zeuzem, MD University Hospital, Frankfurt, Germany Hepatitis C: Difficult-to-treat Patients 11th Paris Hepatology Conference 16th January 2018 Stefan Zeuzem, MD University Hospital, Frankfurt, Germany PHC 2018 - www.aphc.info Disclosures Advisory boards:

More information

Prevalence and Outcomes of Multiple-Listing for Cadaveric Kidney and Liver Transplantation

Prevalence and Outcomes of Multiple-Listing for Cadaveric Kidney and Liver Transplantation American Journal of Transplantation 24; 4: 94 1 Blackwell Munksgaard Copyright C Blackwell Munksgaard 23 doi: 1.146/j.16-6135.23.282.x Prevalence and Outcomes of Multiple-Listing for Cadaveric Kidney and

More information

New Organ Allocation Policy in Liver Transplantation in the United States

New Organ Allocation Policy in Liver Transplantation in the United States REVIEW New Organ Allocation Policy in Liver Transplantation in the United States David A. Goldberg, M.D., M.S.C.E.,*,, Richard Gilroy, and Michael Charlton, MD., F.R.C.P. The number of potential recipients

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL186/2 Copy Number Effective 01/04/14 Summary of Significant Changes Clarification of policy approval process Paragraph 2.2.1 Clarification of Kidney Fast Track Scheme offering criteria

More information

2017 UNOS Liver Distribution Proposal Discussion: David Goldberg

2017 UNOS Liver Distribution Proposal Discussion: David Goldberg 2017 UNOS Liver Distribution Proposal Discussion: David Goldberg Who am I? Transplant hepatologist at the University of Pennsylvania Medical Director of Living Donor Liver Transplant NIH-funded epidemiologist

More information

Update on Kidney Allocation

Update on Kidney Allocation Update on Kidney Allocation 23rd Annual Conference Association for Multicultural Affairs in Transplantation Silas P. Norman, M.D., M.P.H. Associate Professor Division of Nephrology September 23, 2015 Disclosures

More information

2019 Missouri GIS Conference

2019 Missouri GIS Conference 2019 Missouri GIS Conference 2019 Missouri GIS Conference April 29 May 1, 2019 Detailed conference information including the schedule, presentation descriptions, exhibitors and more can be found on the

More information

LIVER TRANSPLANTATION

LIVER TRANSPLANTATION Imtiaz Alam, M.D. Phone: [512] 719-4370 Mandy Mishra, CNS Fax: [512] 719-4371 Austin Hepatitis Center 12201, Renfert Way Suite 235 Austin, TX 78758 LIVER TRANSPLANTATION The liver is the largest and one

More information

Anne Barkman. The University of Kansas School of Nursing

Anne Barkman. The University of Kansas School of Nursing Expanding Donor Criteria: Is it Safe? Anne Barkman The University of Kansas School of Nursing About the author: Anne Barkman is from Leawood, Kansas. She was an academic honor roll recipient for Fall 2010,

More information

SUPPLEMENTARY DATA. Telediab Study Group :

SUPPLEMENTARY DATA. Telediab Study Group : Telediab Study Group : Guillaume Charpentier, MD, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France Centre d Études et de Recherches pour l Intensification du Traitement du Diabète

More information

NHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY

NHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY INTRODUCTION NHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY 1 This paper is a review of the usage of the Adult Urgent Heart Allocation

More information

The New Kidney Allocation System (KAS) Frequently Asked Questions

The New Kidney Allocation System (KAS) Frequently Asked Questions The New Kidney Allocation System (KAS) Frequently Asked Questions Contents General: The Need for the New System and Key Implementation Details... 4 Why was the newly revised KAS necessary?... 4 What were

More information

3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice

3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice 3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice Rome, 13 December 2013 Management and monitoring of HCC in the future era of DAA s Prof. Massimo Colombo Chairman Department of Liver,

More information

Visualizing Health Care for Rural Veterans with GIS

Visualizing Health Care for Rural Veterans with GIS Visualizing Health Care for Rural Veterans with GIS Justin Ahern, GIS Analyst U.S. Department of Veterans Affairs, Office of Rural Health, GeoSpatial Outcomes Division Other authors: Cowper Ripley DC,

More information

Improving efficiency in health. Hepatitis C virus session

Improving efficiency in health. Hepatitis C virus session Improving efficiency in health Hepatitis C virus session Aims of this session Optima is a tool to assist in reducing the burden of diseases by optimizing resource allocation. This session will discuss:

More information

Reconsidering Liver Transplantation for HCC in a Era of Organ shortage

Reconsidering Liver Transplantation for HCC in a Era of Organ shortage Reconsidering Liver Transplantation for HCC in a Era of Organ shortage Professor Didier Samuel Centre Hépatobiliaire Inserm-Paris Sud Research Unit 1193 Departement Hospitalo Universitaire Hepatinov Hôpital

More information

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? Original Article Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? R. F. Saidi 1 *, Y. Li 2, S. A. Shah 2, N. Jabbour 2 1 Division of Organ Transplantation, Department

More information

Florida State University Libraries

Florida State University Libraries Florida State University Libraries Undergraduate Research Honors Ethical Issues and Life Choices (PHI2630) 2013 Ethical Implications of an Amendment to the National Organ Transplant Act of 1984 (NOTA),

More information

Liver Transplantation for the Primary Care Provider. Atif Zaman MD MPH Oregon Health & Sciences University

Liver Transplantation for the Primary Care Provider. Atif Zaman MD MPH Oregon Health & Sciences University Liver Transplantation for the Primary Care Provider Atif Zaman MD MPH Oregon Health & Sciences University Disclosures 1. The speaker/planner Atif Zaman, MD MPH have no relevant financial relationships

More information

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,

More information

Alcoholic Liver Disease as First Indication

Alcoholic Liver Disease as First Indication Alcoholic Liver Disease as First Indication Patrizia Burra Multivisceral Transplant Unit Gastroenterology Department of Surgery, Oncology and Gastroenterology Padua University Hospital, Padua, Italy Patrizia

More information

AGENDA Region 3 Meeting Hilton Garden Inn Atlanta Airport/Millenium Center 2301 Sullivan Rd College Park, GA August 25, 2017

AGENDA Region 3 Meeting Hilton Garden Inn Atlanta Airport/Millenium Center 2301 Sullivan Rd College Park, GA August 25, 2017 AGENDA Region 3 Meeting Hilton Garden Inn Atlanta Airport/Millenium Center 2301 Sullivan Rd College Park, GA August 25, 2017 (Note: All times except the start time are approximate. Actual times will be

More information

Improving liver allocation: MELD and PELD

Improving liver allocation: MELD and PELD American Journal of Transplantation 24; 4 (Suppl. 9): 114 131 Blackwell Munksgaard Blackwell Munksgaard 24 Improving liver allocation: MELD and PELD Richard B. Freeman Jr a,, Russell H. Wiesner b, John

More information

Malawi, : Analyzing HIV/AIDS Trends Using Geographic Information Systems

Malawi, : Analyzing HIV/AIDS Trends Using Geographic Information Systems Malawi, 1994-2010: Analyzing HIV/AIDS Trends Using Geographic Information Systems Eliza Johannes The Problem The longer it took to travel to the nearest public transport, the higher the prevalence of HIV...

More information

Adjusting to life after kidney transplant. Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology

Adjusting to life after kidney transplant. Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology Adjusting to life after kidney transplant Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology Thanks to our speaker! Dr. Rupi Sodhi Assistant Professor of Internal Medicine

More information

Questions and Answers for Transplant Candidates about the Kidney Allocation System

Questions and Answers for Transplant Candidates about the Kidney Allocation System TA L K I N G A B O U T T R A N S P L A N TAT I O N Questions and Answers for Transplant Candidates about the Kidney Allocation System United Network for Organ Sharing (UNOS) is a non-profit charitable

More information

Transplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico

Transplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico Transplant Update New Kidney Allocation System Transplant Referral Strategies Antonia Harford, MD University of New Mexico Financial Disclosures Doctor Harford has received financial support for dialysis

More information

2014 Year End Review

2014 Year End Review End Review Transplants Kidney Kidney Pancreas Pancreas Liver Heart Number of Patients on WaitList as of.. 99 Number Of Patients 9 Kidney Kidney Pancreas Liver Heart Organ Donor Statistics Atlantic Canada

More information

Immunosuppressants, Organ Transplants, and Potential of Regenerative Medicine: Market Size, Competitive Landscape, and Pipeline Analysis

Immunosuppressants, Organ Transplants, and Potential of Regenerative Medicine: Market Size, Competitive Landscape, and Pipeline Analysis Immunosuppressants, Organ Transplants, and Potential of Regenerative Medicine: Market Size, Competitive Landscape, and Pipeline Analysis Introduction This report examines treatment protocols evolved over

More information

EFFECTS OF BUFFER SIZE AND SHAPE ON ASSOCIATIONS BETWEEN THE BUILT ENVIRONMENT AND ENERGY BALANCE

EFFECTS OF BUFFER SIZE AND SHAPE ON ASSOCIATIONS BETWEEN THE BUILT ENVIRONMENT AND ENERGY BALANCE EFFECTS OF BUFFER SIZE AND SHAPE ON ASSOCIATIONS BETWEEN THE BUILT ENVIRONMENT AND ENERGY BALANCE PETER JAMES (HARVARD SCHOOL OF PUBLIC HEALTH) DAVID BERRIGAN (NATIONAL CANCER INSTITUTE) JAIME E HART (HARVARD

More information

The Organ Allocation Controversy: How Did We Arrive Here?

The Organ Allocation Controversy: How Did We Arrive Here? The Organ Allocation Controversy: How Did We Arrive Here? Clifford H. Van Meter, MD Chief of the Division of Cardiothoracic Surgery and Transplantation, Ochsner Clinic and Alton Ochsner Medical Foundation;

More information

Care of the DCD in ICU: the French experience

Care of the DCD in ICU: the French experience Care of the DCD in ICU: the French experience The National Steering Committee of donors after circulatory death C. Antoine 1, M. Videcoq 2, B. Riou 3, D. Dorez 4, G. Cheisson 5, E. Savoye 1,L. Durand 1,

More information

Organ Donation. United States and European Union Perspective

Organ Donation. United States and European Union Perspective Organ Donation United States and European Union Perspective Carina Sokalski - Gonzalo Perez SANIT- December 14, 2004 Two Types of Organ Donation Deceased Organ Donation The majority of organ donors are

More information

Access and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival

Access and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival American Journal of Transplantation 2010; 10 (Part 2): 1090 1107 Wiley Periodicals Inc. Special Feature No claim to original US government works Journal compilation C 2010 The American Society of Transplantation

More information

Liver Transplantation Evaluation: Objectives

Liver Transplantation Evaluation: Objectives Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation

More information

Social Determinants of Health

Social Determinants of Health FORECAST HEALTH WHITE PAPER SERIES Social Determinants of Health And Predictive Modeling SOHAYLA PRUITT Director Product Management Health systems must devise new ways to adapt to an aggressively changing

More information

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Abhi Humar, MD Clinical Director, Thomas E. Starzl Transplantation Institute 1 PITTSBURGH THE BIRTHPLACE OF LIVER TRANSPLANTATION

More information

Opposition principles and Antonyms in Medical Terminological Systems: Structuring Diseases Description with Explicit Existential Quantification

Opposition principles and Antonyms in Medical Terminological Systems: Structuring Diseases Description with Explicit Existential Quantification 1261 Opposition principles and Antonyms in Medical Terminological Systems: Structuring Diseases Description with Explicit Existential Quantification Christian Jacquelinet Agence de la Biomédecines, 1,

More information

2017 Year End Review

2017 Year End Review Number Of Patients End Review Transplants 9 9 Kidney Kidney Pancreas Pancreas Liver Heart Number of Patients on WaitList as of..9 Kidney Kidney Pancreas Pancreas Liver Heart Number of Donors Number of

More information

Journal of the American College of Cardiology Vol. 60, No. 1, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 60, No. 1, by the American College of Cardiology Foundation ISSN /$36. Journal of the American College of Cardiology Vol. 60, No. 1, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.02.031

More information

Clinical Study The Impact of the Introduction of MELD on the Dynamics of the Liver Transplantation Waiting List in São Paulo, Brazil

Clinical Study The Impact of the Introduction of MELD on the Dynamics of the Liver Transplantation Waiting List in São Paulo, Brazil Transplantation, Article ID 219789, 4 pages http://dx.doi.org/1.1155/214/219789 Clinical Study The Impact of the Introduction of MELD on the Dynamics of the Liver Transplantation Waiting List in São Paulo,

More information

Stratégie de transplantation chez le patient diabétique de type 1. Transplantation strategy in Type 1 diabetic patient

Stratégie de transplantation chez le patient diabétique de type 1. Transplantation strategy in Type 1 diabetic patient Stratégie de transplantation chez le patient diabétique de type 1 Transplantation strategy in Type 1 diabetic patient Emmanuel Morelon Service de Transplantation, Néphrologie et Immunologie Clinique Hôpital

More information

Compared efficacy of preservation Solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.

Compared efficacy of preservation Solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. 12/2013 Compared efficacy of preservation Solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. René ADAM, Valérie DELVART, Vincent KARAM, Christian

More information

Racial and Ethnic Disparities in Access to Liver Transplantation

Racial and Ethnic Disparities in Access to Liver Transplantation LIVER TRANSPLANTATION 16:1033-1040, 2010 ORIGINAL ARTICLE Racial and Ethnic Disparities in Access to Liver Transplantation Amit K. Mathur, 1 Douglas E. Schaubel, 2,3 Qi Gong, 2 Mary K. Guidinger, 3,4 and

More information

10:15-10:35 Welcome and update from Regional Councillor Lewis Teperman, MD Northwell Health Region 9 Councillor

10:15-10:35 Welcome and update from Regional Councillor Lewis Teperman, MD Northwell Health Region 9 Councillor AGENDA Region 9 Meeting Renaissance Albany Hotel 144 State Street, Albany, NY September 19, 2017 (Note: All times except the start time are approximate. Actual times will be determined by the amount of

More information

Obesity, Inflammation and Liver Cancer

Obesity, Inflammation and Liver Cancer Obesity, Inflammation and Liver Cancer Richard Moreau, M.D., 1 INSERM U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, 2 Université Denis Diderot Paris 7, 3 Service d Hépatologie, Hôpital Beaujon,

More information

MEETING PROSPECTUS. International Workshop on NASH Biomarkers

MEETING PROSPECTUS. International Workshop on NASH Biomarkers International Workshop on NASH Biomarkers 2018 18-19 May 2018 Washington, D.C., USA MEETING PROSPECTUS www.expertmedicaleducation.com www.expertmedicalevents.com ADVANCING HEALTH GLOBALLY THROUGH INNOVATIVE

More information